Does ADAMTS13, RECOMBINANT-KRHN Cause Thrombotic thrombocytopenic purpura? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Thrombotic thrombocytopenic purpura have been filed in association with ADAMTS13, RECOMBINANT-KRHN. This represents 8.8% of all adverse event reports for ADAMTS13, RECOMBINANT-KRHN.
6
Reports of Thrombotic thrombocytopenic purpura with ADAMTS13, RECOMBINANT-KRHN
8.8%
of all ADAMTS13, RECOMBINANT-KRHN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Thrombotic thrombocytopenic purpura From ADAMTS13, RECOMBINANT-KRHN?
Of the 6 reports, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Thrombotic thrombocytopenic purpura Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADAMTS13, RECOMBINANT-KRHN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ADAMTS13, RECOMBINANT-KRHN Cause?
Pregnancy (9)
No adverse event (7)
Abortion spontaneous (5)
Headache (5)
Incorrect dose administered (5)
What Other Drugs Cause Thrombotic thrombocytopenic purpura?
CLOPIDOGREL BISULFATE (282)
RITUXIMAB (154)
CYCLOSPORINE (95)
CYCLOPHOSPHAMIDE (85)
TACROLIMUS (82)
CAPLACIZUMAB-YHDP (63)
CARFILZOMIB (63)
METHYLPREDNISOLONE (63)
ASPIRIN (60)
QUETIAPINE (58)